CD40LG and COVID-19: Goshua et al. reported a higher level of sP-selectin and sCD40L in ICU patients with COVID-19 compared to the control group suggesting that SARS-CoV-2 induces the release of P-selectin and sCD40L from stimulated endothelial cells and triggers platelet activation.